Literature DB >> 10696079

Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonist.

M Ruiz-Gayo1, M M Garrido, J A Fuentes.   

Abstract

The circadian activity of the hypothalamic-pituitary-adrenal (HPA) axis is regulated by caloric flow in rats. During the dark cycle, it has been shown that, in fasted rats, the time-course profile of plasma concentrations of adrenocorticotropin (ACTH) and corticosterone parallels the profile of food intake in ad libitum fed animals. Cholecystokinin (CCK) is involved in regulating food intake in rodents. CCK-8 reduces food intake by acting on CCK-A receptors subtype. This work aims at establishing an eventual relationship between the modulatory role of CCK on food intake and its effect on HPA axis activity during fasting. We studied the effect of CCK-A and CCK-B receptor antagonists on food intake during the first period of the dark cycle. Under these conditions we observed that the CCK-A receptor antagonist, SR-27897 (0.3 mg kg(-1)), but not the CCK-B receptor antagonist, L-365260 (1 mg kg(-1)), increases food-intake. In a second series of experiments we observed that the increase of both ACTH and corticosterone plasma level elicited by fasting, was prevented by SR-27897, but not by L-365260. These results indicate that CCK-A receptor blockade during fasting prevents the activation of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696079      PMCID: PMC1571903          DOI: 10.1038/sj.bjp.0703117

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

2.  Tissue effects of glucocorticoids.

Authors:  J D Baxter; P H Forsham
Journal:  Am J Med       Date:  1972-11       Impact factor: 4.965

3.  Regulation of activity in the hypothalamo-pituitary-adrenal axis is integral to a larger hypothalamic system that determines caloric flow.

Authors:  S F Akana; A M Strack; E S Hanson; M F Dallman
Journal:  Endocrinology       Date:  1994-09       Impact factor: 4.736

4.  A simple procedure for direct corticosterone radioimmunoassay in the rat.

Authors:  A Armario; J M Castellanos
Journal:  Rev Esp Fisiol       Date:  1984-12

5.  Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

Authors:  R S Chang; T B Chen; M G Bock; R M Freidinger; R Chen; A Rosegay; V J Lotti
Journal:  Mol Pharmacol       Date:  1989-06       Impact factor: 4.436

6.  Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.

Authors:  J N Crawley; S M Fiske; C Durieux; M Derrien; B P Roques
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

7.  Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.

Authors:  D Gully; D Fréhel; C Marcy; A Spinazzé; L Lespy; G Neliat; J P Maffrand; G Le Fur
Journal:  Eur J Pharmacol       Date:  1993-02-23       Impact factor: 4.432

8.  Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids.

Authors:  M D Woods; M J Shipston; E L Mullens; F A Antoni
Journal:  Endocrinology       Date:  1992-12       Impact factor: 4.736

9.  Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.

Authors:  M Poncelet; M Arnone; M Heaulme; N Gonalons; C Gueudet; V Santucci; O Thurneyssen; P Keane; D Gully; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

10.  The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.

Authors:  F Hernando; J A Fuentes; B P Roques; M Ruiz-Gayo
Journal:  Eur J Pharmacol       Date:  1994-08-22       Impact factor: 4.432

View more
  4 in total

1.  Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

2.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

3.  Regulation of leptin distribution between plasma and cerebrospinal fluid by cholecystokinin receptors.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

4.  NanoLuc Bioluminescence-Driven Photodynamic Activation of Cholecystokinin 1 Receptor with Genetically-Encoded Protein Photosensitizer MiniSOG.

Authors:  Yuan Li; Zong Jie Cui
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.